SRRK · Scholar Rock Holding Corp · Executive Compensation
$43.98
+1.07 (+2.49%)
At close · Nov 3
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$5.33B
Shares
121.79M
Volume · Nov 3
676.85K
Avg daily vol (3M)
1.66M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jay Backstrom | M.D., M.P.H. President, and Chief Executive Officer | $7,991,933 |
| Jing Marantz | Chief Medical Officer | $3,078,300 |
| Mo Qatanani | Chief Scientific Officer | $2,959,480 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jay Backstrom | M.D., M.P.H. President, and Chief Executive Officer | $4,111,853 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jay Backstrom | M.D., M.P.H. President and Chief Executive Officer | $7,076,259 |
| Edward H. Myles | M.B.A. Chief Operating Officer & Chief Financial Officer | $3,109,887 |
| Greg Carven | Former Chief Scientific Officer | $3,086,971 |
| Nagesh Mahanthappa | Former Interim Chief Executive Officer and President | $2,843,861 |
| Junlin Ho | General Counsel and Secretary | $2,128,356 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Stuart A. Kingsley | Former President and Chief Executive Officer | $9,615,967 |
| Edward H. Myles | M.B.A. Chief Operating Officer & Chief Financial Officer | $5,516,053 |
| Nagesh Mahanthappa | Former Interim Chief Executive Officer and President | $5,095,264 |
| Yung H. Chyung M.D | Chief Medical Officer | $3,809,382 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stuart A. Kingsley | Former President and Chief Executive Officer | $4,952,846 |
| Nagesh Mahanthappa | Interim Chief Executive Officer and President | $4,131,091 |
| Edward H. Myles | Chief Operating Officer & Chief Financial Officer | $3,116,355 |
| Gregory J. Carven Ph.D | Chief Scientific Officer and former Head of Research | $1,570,631 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Nagesh Mahanthappa | Former President and Chief Executive Officer | $2,158,650 |
| Nagesh K. Mahanthappa Ph.D | President and Chief Executive Officer | $2,158,650 |
| Rhonda M. Chicko | C.P.A, Former Chief Financial Officer | $1,473,278 |
| Yung H. Chyung | — | $1,169,527 |
| Alan J. Buckler | Chief Scientific Officer | $1,093,972 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Nagesh K. Mahanthappa Ph.D | President and Chief Executive Officer | $3,042,227 |
| Rhonda M. Chicko | C.P.A, Former Chief Financial Officer | $1,641,828 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Erin Moore | interim Principal Accounting Officer and interim Principal Financial Officer | Resigned | 2025-04-28 |
| R. Keith Woods | Chief Operating Officer | Appointed | 2025-04-28 |
| Vikas Sinha | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Appointed | 2025-04-28 |
| Akshay Vaishnaw | President of Research & Development | Appointed | 2025-04-28 |
| Jay T. Backstrom | member of the Board | Resigned | 2025-04-28 |
| David Hallal | Chief Executive Officer | Appointed | 2025-04-28 |
| Erin Moore | interim Principal Accounting Officer | Appointed | 2025-03-21 |
| Erin Moore | interim Principal Financial Officer | Appointed | 2025-03-21 |
| Lisa Wyman | Chief Technical and Quality Officer | Appointed | 2025-01-29 |
| Lisa Wyman | Chief Technical and Quality Officer | Appointed | 2025-01-29 |
| Katie Peng | Class II director | Appointed | 2024-02-15 |
| Richard Brudnick | director | Appointed | 2023-04-10 |
| Jing Marantz | Chief Medical Officer | Appointed | 2022-11-09 |
| Jay Backstrom, M.D., M.P.H. | President & CEO | Appointed | 2022-09-20 |
| Jay Backstrom, M.D., M.P.H. | Board of Directors | Appointed | 2022-09-20 |
| Jay Backstrom, M.D., M.P.H. | Chief Executive Officer-Elect | Appointed | 2022-09-20 |
| Jay Backstrom | Chief Executive Officer | Appointed | 2022-09-20 |
| Nagesh Mahanthappa | member of the Board | Resigned | 2022-09-20 |
| Nagesh Mahanthappa | Interim Chief Executive Officer and President | Resigned | 2022-09-20 |
| Dr. Jay Backstrom | Class 1 director of the Board | Appointed | 2022-09-20 |
| Dr. Jay Backstrom | Chief Executive Officer-Elect | Appointed | 2022-09-20 |
| Srinivas Akkaraju | Class I director | Appointed | 2022-07-26 |
Leadership
- David Hallal CEO, Board Member
- Dr. Jay Backstrom CEO, Board Member
- Jay Backstrom, M.D., M.P.H. CEO, Board Member
- Nagesh K. Mahanthappa Ph.D CEO
- Erin Moore CFO, Chief Accounting Officer
- Rhonda M. Chicko CFO
- Vikas Sinha CFO
- R. Keith Woods COO
- Junlin Ho General Counsel, Board Member
- Caryn Parlavecchio Board Member
- Jing Marantz Board Member
- Katie Peng Board Member
- Keith Woods Board Member
- Kristina Burow Board Member
- Lisa Wyman Board Member
- Michael Gilman Board Member
- Mo Qatanani Board Member
- Tony Kingsley Board Member
Key facts
CIK
1727196
CUSIP
80706P103
13F (30d)
73 filings
65 filers
Visit website
Investor relations